Bank of Montreal Can Trims Position in Nutrien Ltd. (NYSE:NTR)

Bank of Montreal Can lessened its holdings in shares of Nutrien Ltd. (NYSE:NTRFree Report) by 2.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 13,857,124 shares of the company’s stock after selling 299,363 shares during the quarter. Bank of Montreal Can owned about 2.82% of Nutrien worth $619,252,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of NTR. Uncommon Cents Investing LLC lifted its stake in shares of Nutrien by 2.1% in the 4th quarter. Uncommon Cents Investing LLC now owns 11,550 shares of the company’s stock valued at $517,000 after purchasing an additional 235 shares during the last quarter. Rhumbline Advisers grew its holdings in Nutrien by 3.5% during the 4th quarter. Rhumbline Advisers now owns 7,398 shares of the company’s stock worth $331,000 after acquiring an additional 247 shares in the last quarter. FFT Wealth Management LLC lifted its holdings in Nutrien by 0.9% during the fourth quarter. FFT Wealth Management LLC now owns 29,732 shares of the company’s stock worth $1,330,000 after buying an additional 277 shares during the period. EverSource Wealth Advisors LLC grew its stake in Nutrien by 23.9% in the fourth quarter. EverSource Wealth Advisors LLC now owns 1,804 shares of the company’s stock valued at $81,000 after purchasing an additional 348 shares during the last quarter. Finally, PFG Investments LLC raised its stake in shares of Nutrien by 2.0% during the 4th quarter. PFG Investments LLC now owns 20,097 shares of the company’s stock worth $899,000 after acquiring an additional 386 shares in the last quarter. 63.10% of the stock is currently owned by institutional investors.

Nutrien Stock Performance

Shares of Nutrien stock opened at $47.44 on Monday. The firm’s 50-day simple moving average is $51.30 and its 200-day simple moving average is $49.12. Nutrien Ltd. has a 1 year low of $43.70 and a 1 year high of $60.87. The firm has a market cap of $23.19 billion, a PE ratio of 34.63, a price-to-earnings-growth ratio of 1.19 and a beta of 0.77. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.82 and a current ratio of 1.27.

Nutrien (NYSE:NTRGet Free Report) last posted its earnings results on Wednesday, February 19th. The company reported $0.28 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.09). The company had revenue of $5.08 billion during the quarter, compared to the consensus estimate of $5.09 billion. Nutrien had a net margin of 2.62% and a return on equity of 6.81%. Equities analysts forecast that Nutrien Ltd. will post 3.72 earnings per share for the current fiscal year.

Nutrien Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 10th. Investors of record on Monday, March 31st will be paid a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a dividend yield of 4.60%. The ex-dividend date is Monday, March 31st. Nutrien’s payout ratio is 159.12%.

Analysts Set New Price Targets

NTR has been the subject of a number of research analyst reports. Oppenheimer initiated coverage on shares of Nutrien in a report on Thursday, December 12th. They issued an “outperform” rating and a $60.00 price target for the company. The Goldman Sachs Group initiated coverage on shares of Nutrien in a report on Thursday, March 13th. They set a “sell” rating and a $53.00 price target on the stock. Royal Bank of Canada reissued an “outperform” rating and issued a $60.00 price objective on shares of Nutrien in a report on Monday, February 24th. Barclays lifted their price objective on Nutrien from $56.00 to $59.00 and gave the stock an “equal weight” rating in a report on Wednesday, March 5th. Finally, UBS Group boosted their price target on shares of Nutrien from $53.00 to $54.00 and gave the stock a “neutral” rating in a research report on Thursday, February 20th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $60.00.

View Our Latest Stock Report on NTR

Nutrien Company Profile

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Further Reading

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.